Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
It was clinically approved by both the Food and Drug Administration (FDA) and the European Medicine Agency (EMA) in 2014 for the treatment of relapsing-remitting multiple sclerosis (MS), showing a significant efficacy over 2 years versus placebo and a favorable benefit-risk profile in two phase-III clinical trials, although with several adverse effects such as nausea, diarrhea, abdominal pain and leukopenia in some patients [282, 283]
Certificate of Analysis Every batch undergoes rigorous third-party laboratory testing to verify identity, purity (98%), and quality before release
L-Acetyl-carnitine in patients with carpal tunnel syndrome: effects on nerve protection, hand function and pain
Tsao, R
Glutathione neutralizes free radicals, reducing inflammation and speeding recovery
US$ 22.47
US$ 21.94
US$ 25.41
US$ 24.45
